Pure Global

The role of routine home visits by community health workers - Trial PACTR202212839343068

Access comprehensive clinical trial information for PACTR202212839343068 through Pure Global AI's free database. This Phase 2 trial is sponsored by School of Economics at Henan University and is currently Recruitment Completed. The study focuses on Cardiology.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR202212839343068
Phase 2
Recruitment Completed
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR202212839343068
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The role of routine home visits by community health workers
The role of CHW's home health visits on medication adherence among chronically-illed elderly

Study Focus

Cardiology

Sponsor & Location

School of Economics at Henan University

School of Economics Henan University Research and Development Fund

United Republic of Tanzania

Timeline & Enrollment

Phase 2

Jun 25, 2022

Nov 13, 2022

Summary

Background of the study:This study is designed to understand the challenges regarding access of care, particularly those living in the rural area, and the effect of a potential intervention aiming at improving access. The intervention involves routine home visits by community health workers with basic health consultation, temperature check, blood pressure check, and providing a medication uptake schedule reminder.ย Objectives of the study:To improve medication adherence also decrease/minimize unnecessary health care utilization.

ICD-10 Classifications

Cardiomyopathy
Cardiomegaly
Cardiac catheterization
Cardiomyopathy, unspecified
Injury of heart

Data Source

Pan Africa Clinical Trials Registry

PACTR202212839343068

Non-Device Trial